Building Blocks

Ethyl 2-(3-nitrophenyl)acetate is an organic compound. It is a chloride channel blocker that has been shown to inhibit the activity of multidrug-resistant proteins (e.g., p-glycoprotein and multidrug resistance protein). The uptake of this drug in cells is limited by its low oral bioavailability and its interaction with aluminium ions. This drug interacts with multidrug-resistance proteins, which are involved in the transport of drugs or toxins out of the cell, by competing for binding sites. Ethyl 2-(3-nitrophenyl)acetate inhibits the catalytic activity of these proteins, leading to a regression in multidrug resistance. It can also inhibit the activity of isoxazoles and alcohols.br>br>/p>

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

4,4'-Carbonyldimorpholine is a thioxanthone that can be used in coatings and UV-curable inks. It is a cationic monomer that can polymerize with other monomers to form polymers with high molecular weight. 4,4'-Carbonyldimorpholine also reacts with fatty acids to produce water-soluble polymers and amines to produce water-insoluble polymers. This agent has been shown to interact with the surface of metals and acrylates, which are compounds that are used in coatings and UV-curable inks. The nature of this compound is dependent on the environment it is exposed to.

Methyl 2,2-diMethylacetoacetate is a deuterated acetoacetate. It has a transition state that is oriented. This acetoacetate can be modified by modifiers such as transition metals and ligands. The methyl group can be removed from the molecule by hydrolysis or hydrogenation to form 2,3-dihydroxypropanoic acid.

Versatile small molecule scaffold

Versatile small molecule scaffold

Versatile small molecule scaffold

2-Methylsulfonylthiophene is a modulating agent that can inhibit the activity of carbonic anhydrase, adenosine receptors and 5-membered heteroaryl. It has been shown to have affinity for CB1 receptor antagonists and is used to treat cardiovascular diseases. 2-Methylsulfonylthiophene also inhibits the enzymatic activity of anhydrase in the eye, which leads to suppression of intraocular pressure (IOP). The drug also has anti-glaucoma effects by reducing the production of aqueous humour. 2-Methylsulfonylthiophene is used as a dyestuff intermediate and as an organic solvent.

4-chlorotetrahydro-2H-thiopyran 1,1-dioxide is an experimental heterocyclic compound. It has a dipole and a methylcyclohexane ring with an axial orientation. The density of the molecule is 1.499 g/cm3. This compound has conformational energies and substituents that are stable at room temperature. Theory predicts that this compound will have 3 conformers, all of which are energetically favorable, with one being more stable than the others. The energies and conformers are influenced by the steric interactions between substituents and cyclohexanes in the molecule. 4-chlorotetrahydro-2H-thiopyran 1,1-dioxide has no electrostatic interactions because it does not have any electronegative atoms or groups.

Cyclopropyl(3,4-dimethylphenyl)methanone (CPM) is a synthetic cannabinoid that has been shown to have similar effects to the natural cannabinoids found in cannabis. CPM binds to and activates the CB2 receptor, which is found on cells of the immune system, brain, and other organs. It has been studied for its ability to reduce glioma tumor growth in mice by inhibiting glutamate release. The molecular modeling study showed that CPM binds to the receptor with a geometry similar to other CB2 agonists like JWH-133. In addition, CPM inhibits locomotor activity in rats and has been shown to produce some symptoms of anxiety in mice. A receptor knockout study with mice showed that CPM can bind to CB2 receptors without activating them. X-ray diffraction data indicated that CPM is an achiral molecule with an idealized molecular geometry of "s".